——
Weiyuan Biotechnology is a company that uses the intelligent evolution of enzymes and high-throughput screening of strains as its technical engine, precise analysis and intelligent prediction based on the "Compendium of Materia Medica" formula as its technical means, and billions of natural and artificial enzyme elements through scientific planning, simulation calculation, and rational design, committed to building a leading enzyme library with over a thousand varieties, broad-spectrum universality, and highly representative. It provides a series of high-performance "chip" devices for the biological manufacturing industry, and applies these high-performance biological elements to the efficient production of chiral compounds, enzymatic hydrolysis efficiency of active natural products, and rapid construction of cell-free multi enzyme cascade systems in synthetic biology. At the beginning of its establishment, Weiyuan Biotechnology received unanimous praise and strong support from numerous experts in various fields such as well-known research institutes, the biopharmaceutical industry, and venture capital institutions. Weiyuan Biology plans to invest over 100 million yuan in two years to build a synthetic biology intelligent manufacturing platform without walls, becoming a phenomenal life science decoding tool.